Vivimed Labs Standalone December 2023 Net Sales at Rs 37.14 crore, down 26.55% Y-o-Y
February 16, 2024 / 11:57 IST
Reported Standalone quarterly numbers for Vivimed Labs are:Net Sales at Rs 37.14 crore in December 2023 down 26.55% from Rs. 50.56 crore in December 2022.
Quarterly Net Loss at Rs. 16.17 crore in December 2023 up 15.44% from Rs. 19.12 crore in December 2022.
EBITDA stands at Rs. 0.92 crore in December 2023 up 114.94% from Rs. 6.16 crore in December 2022.
| Vivimed Labs shares closed at 4.95 on July 31, 2023 (NSE) and has given -52.40% returns over the last 12 months. |
| Vivimed Labs | | Standalone Quarterly Results | in Rs. Cr. |
|
| Dec'23 | Sep'23 | Dec'22 | | Net Sales/Income from operations | 37.14 | 30.28 | 50.56 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 37.14 | 30.28 | 50.56 | | EXPENDITURE | | Consumption of Raw Materials | 19.76 | 16.99 | 34.12 | | Purchase of Traded Goods | -- | -- | -- | | Increase/Decrease in Stocks | 0.31 | 0.38 | 1.45 | | Power & Fuel | -- | -- | -- | | Employees Cost | 8.59 | 8.59 | 8.44 | | Depreciation | 4.49 | 4.49 | 3.80 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 7.59 | 9.73 | 12.71 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | -3.60 | -9.89 | -9.97 | | Other Income | 0.04 | 2.16 | 0.01 | | P/L Before Int., Excpt. Items & Tax | -3.57 | -7.74 | -9.96 | | Interest | 13.16 | 11.82 | 9.16 | | P/L Before Exceptional Items & Tax | -16.72 | -19.56 | -19.12 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | -16.72 | -19.56 | -19.12 | | Tax | -0.55 | -- | -- | | P/L After Tax from Ordinary Activities | -16.17 | -19.56 | -19.12 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | -16.17 | -19.56 | -19.12 | | Equity Share Capital | 16.58 | 16.58 | 16.58 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | -1.25 | -2.36 | -0.22 | | Diluted EPS | -1.22 | -2.29 | -0.23 | | EPS After Extra Ordinary | | Basic EPS | -1.25 | -2.36 | -0.22 | | Diluted EPS | -1.22 | -2.29 | -0.23 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
